Upcoming Events
We speak at a number of industry events and conferences throughout the year.
- 8:30 a.m. (EST) / 1:30 p.m. (GMT)
- George Tziras, CEO, and Dr. Carol Routledge, CMSO
Small Pharma to discuss results of SPL026 Phase IIa trial for Major Depressive Disorder and host conference call on Wednesday, January 25
Our management team will host a conference call to discuss the topline results from our Phase IIa trial of SPL026 in Major Depressive Disorder.
Conference Call and Webcast Details:
Dial-in number (from US): +1-877-423-9813
Dial-in number (from outside US):+1-201-689-8573
Conference ID: 13735973
Webcast (to view presentation slides): https://viavid.webcasts.com/starthere.jsp?ei=1595427&tp_key=af827d4034
Past Events
Find recordings and details for recent events below or delve into our archive of all past events and conferences.
Small Pharma to announce results of SPL026 Phase IIa trial for Major Depressive Disorder and host conference call on Wednesday, January 25
Small Pharma will host a conference call to discuss the results of the study.
Small Pharma To Participate In Upcoming Canaccord Genuity Investor Symposium
Small Pharma To Participate In Upcoming Canaccord Genuity Investor Symposium.
Small Pharma To Participate In November Investor And Healthcare Conferences
Small Pharma to participate in Jefferies Conference and CNS Summit.
Small Pharma To Participate In Upcoming September Investor Conferences
Small Pharma to participate in H.C. Wainwright and Jefferies conferences.
Small Pharma to participate in the H. C. Wainwright 1st Annual Mental Health Conference on June 27, 2022
Small Pharma to participate in the H. C. Wainwright 1st Annual Mental Health Conference.
Small Pharma to present at the Jefferies Healthcare Conference in New York City on June 10, 2022
Small Pharma to present at the Jefferies Healthcare Conference in New York City.
Small Pharma to Participate in the PSYCH Symposium: London May 11, 2022
Small Pharma to participate in the PSYCH Symposium, London 2022.
Small Pharma To Present at the KCSA Psychedelics Virtual Investor Conference on April 28, 2022
Small Pharma to present at the KCSA Psychedelics Virtual Investor Conference.
Small Pharma CEO Peter Rand & CMSO Dr Carol Routledge at the 34th Annual Roth Conference
Small Pharma to present at the 34th Annual Roth Conference in March.